Invivyd IVVD
NASDAQ IVVD
$0.87 +0.01 (+1.75%)
As of: Sep 30, 2026 · 3:59 PM EDT

Invivyd (IVVD) EPS (Basic) (2021 - 2026)

Updated

Invivyd (IVVD) recorded EPS (Basic) of -$0.14 in Q2 2026, compared with -$0.12 a year earlier.

Analysis

Invivyd (IVVD) EPS (Basic) (2021 - 2026) Analysis & Trends

On a TTM basis, Invivyd's EPS (Basic) came in at -$0.25 as of Jun 30, 2026; for FY2025, it was -$0.30.

  • Across earlier years, EPS (Basic) came in at -$1.43 in FY2024, -$1.81 in FY2023, -$2.23 in FY2022 and -$5.32 in FY2021.
  • The Q2 2026 figure is the lowest quarterly EPS (Basic) since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 2.30
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 2.04
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -0.54
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 1.68
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 1.87
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 4.40
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -8.44
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 4.34
10 Invivyd 250.54 Mn -256.10 Mn 13.01 Mn -0.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.14
Dec 31, 2025 -0.06
Sep 30, 2025 -0.06
Jun 30, 2025 -0.12
Mar 31, 2025 -0.14
Dec 31, 2024 -0.16
Sep 30, 2024 -0.51
Jun 30, 2024 -0.40
Mar 31, 2024 -0.38
Dec 31, 2023 -0.67
Sep 30, 2023 -0.36
Jun 30, 2023 -0.46
Mar 31, 2023 -0.32
Dec 31, 2022 -0.41
Sep 30, 2022 -0.42
Jun 30, 2022 -0.47
Mar 31, 2022 -0.93
Dec 31, 2021 -1.95
Sep 30, 2021 -0.98
Jun 30, 2021 -178.86
API Access

Invivyd EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=IVVD&period=max&api_key=YOUR_API_KEY